Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Zhonghua Kou Qiang Yi Xue Za Zhi ; 57(3): 258-265, 2022 Mar 09.
Artículo en Chino | MEDLINE | ID: mdl-35280003

RESUMEN

Objective: To evaluate the risk factors of inferior alveolar nerve injury (IANI) after surgical removal of the mandibular third molars (M3) and present a new risk scoring system to predict the probability of IANI. Methods: Patients who underwent extraction of M3 in the Stomatology Hospital, Zhejiang University School of Medicine from April 2017 to December 2019 were involved. The investigators enrolled a sample composed of 949 mandibular third molars. Prediction model was used for univariate and multivariate analysis of gender, age, M3, inferior alveolar canal (IAC), and the contact between M3 and IAC, to assess the risk factors of IANI. Combined with the risk factors determined by the outcomes of prediction model, the risk scoring system was constructed. The diagnostic performance of each cut-off score was examined to conduct a risk stratification of IANI risk scores. The predictive ability and reliability of the model were evaluated. Results: In prediction model, twenty nine cases (4.4%, 29/664) experienced postoperative IANI. Number of root (P<0.01), depth of impaction (P<0.05), contact between M3 and IAC (P<0.01) and their contact position (P<0.05) were statistically significant as contributing risk factors of IANI. Specifically, the incidence of temporary IANI was higher in those who aged under 25 years (P<0.001), while female suffer more permanent injury (P<0.05). Based on the IANI risk scoring system, patients were stratified into low-risk, middle-risk and high-risk groups at cutoff scores of 3 and 4. The area under the receiver operator characteristic curve of the risk scoring system were 0.81 [95%CI (0.70-0.90), P=0.002] and 0.80 [95%CI (0.68-0.92), P=0.007] towards good discrimination. Conclusions: Age, gender, number of root, depth of impaction, and contact between M3 and IAC were risk factors of IANI. IANI risk scoring system might help in preoperative assessment, recognition of high-risk cases and decision-making to reduce IANI.


Asunto(s)
Tercer Molar , Traumatismos del Nervio Trigémino , Anciano , Femenino , Humanos , Mandíbula/cirugía , Nervio Mandibular , Tercer Molar/cirugía , Reproducibilidad de los Resultados , Factores de Riesgo , Extracción Dental/efectos adversos , Traumatismos del Nervio Trigémino/epidemiología , Traumatismos del Nervio Trigémino/etiología
2.
Xenobiotica ; 39(10): 711-21, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19552531

RESUMEN

The effects of folic acid-induced acute renal failure on the renal excretion of belotecan were investigated in rats after intravenous administration. Both glomeruli and renal tubules were seriously damaged by folic acid-induced acute renal failure. The renal excretion clearance, CLr, of belotecan was significantly decreased by folic acid-induced acute renal failure. Furthermore, glomerular filtration rate and secretion clearance of the drug were dramatically decreased by folic acid-induced acute renal failure. In vivo renal uptake of belotecan was inhibited by p-aminohippurate, whereas renal excretion was inhibited by GF120918, but not by verapamil and bromosulphalein. This indicates that Oat1/3 and Bcrp are involved in the renal uptake and urinary excretion of belotecan, respectively. Both mRNA and protein levels of Oat1, Oat3 and Bcrp were significantly decreased in folic acid-induced acute renal failure rats. Based on the finding that belotecan is a substrate of OAT1 but not of OAT3, the decrease in CLr of belotecan in folic acid-induced acute renal failure could, therefore, mainly be attributed to the down-regulation of Oat1 and Bcrp, in addition to the decrease in glomerular filtration rate.


Asunto(s)
Lesión Renal Aguda/metabolismo , Antineoplásicos/farmacocinética , Antineoplásicos/orina , Camptotecina/análogos & derivados , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/antagonistas & inhibidores , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 2 , Transportadoras de Casetes de Unión a ATP/antagonistas & inhibidores , Transportadoras de Casetes de Unión a ATP/metabolismo , Acridinas/farmacología , Lesión Renal Aguda/inducido químicamente , Animales , Antineoplásicos/química , Bloqueadores de los Canales de Calcio/farmacología , Camptotecina/química , Camptotecina/farmacocinética , Camptotecina/orina , Regulación hacia Abajo/efectos de los fármacos , Regulación hacia Abajo/fisiología , Ácido Fólico/farmacología , Tasa de Filtración Glomerular/efectos de los fármacos , Indicadores y Reactivos/farmacología , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/patología , Masculino , Proteína 1 de Transporte de Anión Orgánico/antagonistas & inhibidores , Proteína 1 de Transporte de Anión Orgánico/metabolismo , Ratas , Ratas Sprague-Dawley , Tetrahidroisoquinolinas/farmacología , Verapamilo/farmacología , Complejo Vitamínico B/farmacología , Ácido p-Aminohipúrico/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA